Mycosynthetix owns a unique collection of fungi that are the source of a rich variety of fungal metabolites for lead discovery for medicine and agriculture.

Mycosynthetix Awarded 2 Therapeutic Discovery Project Grants

Mycosynthetix, Inc has been awarded two Therapeutic Discovery Project Grants by the IRS. The grants are for projects that “showed significant potential to produce new and cost-saving therapies, support jobs and increase U.S. competitiveness.” More information is available on theĀ IRS website.

The grants were awarded for the following projects:
New Antibiotics for TB from Unusual Fungi
New Cancer Medicines from Unusual Fungi

,